comparemela.com
Home
Live Updates
EYLEA® (aflibercept) IPR and BPCIA Litigation Updates |
EYLEA® (aflibercept) IPR and BPCIA Litigation Updates |
EYLEA® (aflibercept) IPR and BPCIA Litigation Updates | Venable LLP
There has been a flurry of activity relating to proposed EYLEA® (aflibercept) biosimilars in November, starting with a BPCIA litigation against Celltrion’s proposed biosimilar CT-P42...
Related Keywords
United States ,
Samsung Bioepis ,
April Breyer Menon ,
Biocon Biologicspetitionedregeneron ,
Biocon Biologics Mylan Viatris ,
Mylan Biocon ,
Biocon ,
Biocon Biologics ,